Nutex Health Inc expected to post a loss of 12 cents a share - Earnings Preview

Nutex Health

25/03/2025 20:03

Nutex Health Inc NUTX.OQ NUTX.O is expected to show a rise in quarterly revenue when it reports  results on March 27 for the period ending December 31 2024

The Houston Texas-based  company is expected to report a 16.4% increase in revenue to $81.125 million from $69.67 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Nutex Health Inc is for a loss of 12 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Nutex Health Inc is $60.00​, above​ its last closing price of $59.50. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Sep. 30 2024
-0.20
-0.24
-1.72
Missed
-616.7
Jun. 30 2024
-0.29
-0.29
-0.07
Beat
75.9
Mar. 31 2024
0.00
-0.60
Missed
​
Dec. 31 2023
0.00
0.00
Met
​​Sep. 30 2023
-0.75
-1.50
Missed
-100
Jun. 30 2023
-1.50
-0.75
-1.50
Missed
-100​
Mar. 31 2023
-2.26
-2.25
-1.50
Beat
33.3
Dec. 31 2022
-2.36
-2.25
-3.00
Missed
-33.3

This summary was machine generated March 25 at 20:02 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)